|
KONDO Tsunenori
Department School of Medicine(Tokyo Women's Medical University Adachi Medical Center), School of Medicine Position Professor |
|
| Article types | Original article |
| Language | English |
| Peer review | Peer reviewed |
| Title | Time to progression after first-line tyrosine kinase inhibitor predicts survival in patients with metastatic renal cell carcinoma receiving second-line molecular-targeted therapy. |
| Journal | Formal name：Urologic oncology Abbreviation：Urol Oncol ISSN code：10781439 |
| Domestic / Foregin | Foregin |
| Volume, Issue, Page | 35(9),pp.542.e1-542.e9 |
| Author and coauthor | ISHIHARA Hiroki†, KONDO Tsunenori*, YOSHIDA Kazuhiko, OMAE Kenji, TAKAGI Toshio, IIZUKA Junpei, TANABE Kazunari |
| Authorship | 2nd author,Corresponding author |
| Publication date | 2017/09 |
| DOI | 10.1016/j.urolonc.2017.05.014 |